1ST INTERNATIONAL BASIC ONCOLOGY CONGRESSGirişenS. 1-17EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENTÖmer KüçükDOI :10.26650/JARHS2021-1133643Toplantı ÖzetienS. 19-19DISCOVERY OF NOVEL EPIGENETIC BIOMARKERS IN ORAL MALIGNANT LESIONS BY EPIGENOMICS AND TRANSCRIPTOMICS APPROACHESSemra Demokan, Sena Şen, Begüm Özemek, Sevde Cömert, Önder Eryılmaz, Murat Ulusan, Necati Enver, Uğur Sezerman, Gülsüm Ak, F. Canan Alatlı, Mehmet Nejat DalayDOI :10.26650/JARHS2021-1142672Toplantı ÖzetienS. 20-20DATA SCIENCE, CANCER AND SEQUENCING ANALYSESMehmet BaysanDOI :10.26650/JARHS2021-1135821Toplantı ÖzetienS. 21-21TUMOR-ASSOCIATED MICROBIOMEAyşe CanerDOI :10.26650/JARHS2021-1136692Toplantı ÖzetienS. 22-22DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPYGüneş EsendağlıDOI :10.26650/JARHS2021-1138032Toplantı ÖzetienS. 23-23IMPACT OF COMPREHENSIVE GENOMIC PROFILING NGS PANELS IN PRECISION ONCOLOGY: THE CITY OF HOPE CMDL EXPERIENCEMilhan TelatarDOI :10.26650/JARHS2021-1135931Toplantı ÖzetienS. 24-24STEROIDOGENESIS PATHWAY AND BREAST CANCER: EMPOWERING PERSONALIZED TREATMENT WITH A METABOLOMICS APPROACHMete Bora TüzünerDOI :10.26650/JARHS2021-1136824Toplantı ÖzetienS. 25-25DETERMINATION OF THE THERAPEUTIC EFFECT OF VULPINIC ACID AND VULPINIC ACID-RESPONSIVE miR-197-3P IN BREAST CANCER TREATMENT BY IN VITRO AND IN VIVO STUDIESDemet Cansaran DumanDOI :10.26650/JARHS2021-1136842Toplantı ÖzetienS. 26-26WHEN MEIS IS UP IN PROSTATE CANCER, THEN MEISi?Birkan Girgin, Dilek Telci Temeltaş, Yurdanur Süllü, Kaan Öztürk, Fatih KocabaşDOI :10.26650/JARHS2021-1133467Toplantı ÖzetienS. 27-27NEXT-GENERATION SEQUENCING IN CANCER: GENETIC DIAGNOSIS, RISK PREDICTION AND CLASSIFICATIONÖzkan ÖzdemirDOI :10.26650/JARHS2021-1138077Toplantı ÖzetienS. 28-28APPLICATIONS OF TRANSCRIPTOMICS METHODS IN BREAST CANCERYeşim Gökmen PolarDOI :10.26650/JARHS2021-1134635Toplantı ÖzetienS. 29-29PRECISION ONCOLOGY- BASIC TO BEDSIDEAmit VermaDOI :10.26650/JARHS2021-1138049Toplantı ÖzetienS. 30-30THERAPEUTIC IMPLICATIONS OF TARGETED SEQUENCING AND miRNA-SEQ OF B CELL LYMPHOMASEsra Esmeray Sönmez, Tevfik Hatipoğlu, Xiaozhou Hu, Hongling Yuan, Ayça Erşen Danyeli, Ayla Anar Arıcı, Ahmet Şeyhanlı, Zuhal Önder Siviş, Bengü Demirag, Eda Ataseven, Dilek İnce, Zekiye Altun, Safiye Aktaş, İnci Alacacıoğlu, Tuğba Önal Süzek, Nazan Özsan, Taner Kemal Erdağ, Elvan Çağlar Çıtak, Sermin Özkal, Mehmet Ali Özcan, Nazan Çetingül, Erdener Özer, Tezer Kutluk, Nur Olgun, Can KüçükDOI :10.26650/JARHS2021-1138755Toplantı ÖzetienS. 31-31DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCERGizem Çalıbaşı KoçalDOI :10.26650/JARHS2021-1135830Toplantı ÖzetienS. 32-32REAL WORLD EVIDENCE AND BIG DATAMehmet Güven GünverDOI :10.26650/JARHS2021-1132473Toplantı ÖzetienS. 33-33TRANSLATIONAL RESEARCH ETHICSAli Yağız Üresin, Şebnem DönmezDOI :10.26650/JARHS2021-1135109Toplantı ÖzetienS. 34-34TRANSCRIPTOMIC DIFFERENCES IN MONOZYGOTIC TWINS WITH OVARIAN CANCERGözde Kuru Türkcan, Demet Akdeniz Ödemiş, Büşra Kurt, Şeref Buğra Tunçer, Seda Kılıç Erciyas, Özge Şükrüoğlu Erdoğan, Hülya YazıcıDOI :10.26650/JARHS2021-1137404Toplantı ÖzetienS. 36-36miR-3653-3P EXPRESSION IN PERIPHERAL BLOOD OF PATIENTS WITH OVARIAN CARCINOMAFatma Seher Pektopal Delek, Demet Akdeniz Ödemiş, Özge Şükrüoğlu Erdoğan, Seda Kılıç Erciyas, Büşra Kurt, Şeref Buğra Tunçer, Hülya YazıcıDOI :10.26650/JARHS2021-1136829Toplantı ÖzetienS. 37-37INVESTIGATION OF THE EXPRESSION LEVEL OF miR 142-3P IN OVARIAN CARCINOMAYasemin Gider, Xhariqa Jabbarlı, Gamze Uyaroğlu, Demet Akdeniz Ödemiş, Şeref Buğra Tunçer, Büşra Kurt, Seda Kılıç Erciyas, Özge Şükrüoğlu Erdoğan, Betül Çelik, Hülya YazıcıDOI :10.26650/JARHS2021-1138055Toplantı ÖzetienS. 38-38DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCERMilad Asadi, Dariush Shanehbandı, Shahriar Hashemzadeh, Habib Zarehdar, Shahram Ghasembaıglou, Venus Zafari, Tuoraj Asvadi Kermani, Ayşe CanerDOI :10.26650/JARHS2021-1136707Toplantı ÖzetienS. 39-39PRECISION MEDICINE IN NEUROBLASTOMA: EXPERIENCE WITH NEXT GENERATION SEQUENCINGTekincan Çağrı Aktaş, Deniz Kızmazoğlu, Safiye Aktaş, Özde Gökbayrak, Emre Çeçen, Dilek İnce, Zekiye Altun, Nur OlgunDOI :10.26650/JARHS2021-1134059Toplantı ÖzetienS. 40-40REPURPOSING DRUGS FOR CANCER THERAPYEge Arzuk, Ali Ergüç, Fuat KarakuşDOI :10.26650/JARHS2021-1133474Toplantı ÖzetienS. 41-41THE EFFECT OF SILENCING THE Tip60 GENE ON THE RESPONSE TO RADIOTHERAPY IN BREAST CANCER CELLSEce Miser Salihoğlu, Bensu Karahalil, Sevgi Yardım AkaydınDOI :10.26650/JARHS2021-1133481Toplantı ÖzetienS. 42-42INVESTIGATION OF CIRCULAR RNAs AS BIOMARKERS IN HEAD AND NECK CANCER CELLS AND THE EFFECTS OF RADIOTHERAPY ON CIRCULAR RNAsCan Müftüoğlu, Ufuk Mert, Emin Tavlayan, Milad Asadi, Özlem Özkaya Akagündüz, Ayşe CanerDOI :10.26650/JARHS2021-1136808Toplantı ÖzetienS. 43-43EXOSOMES – A NEW FRONTIER IN CANCER THERAPYSevgi GeziciDOI :10.26650/JARHS2021-1133477Toplantı ÖzetienS. 44-44NOVEL EPIGENETIC BIOMARKER DETERMINATION FOR OSCC BY ARRAY-BASED EPIGENOMIC AND TRANSCRIPTOMIC TECHNIQUESSemra Demokan, Sena Şen, Önder Eryılmaz, Sevde Cömert, Murat Ulusan, Mehmet Nejat DalayDOI :10.26650/JARHS2021-1142702Toplantı ÖzetienS. 45-45METHYLATION AND EXPRESSION VALIDATION RESULTS OF GPRC5C GENE OBTAINED FROM EPIGENOMICS AND TRANSCRIPTOMICS DATA IN ORAL CAVITY TUMORSGizem Esentürk, Can Doruk, Murat Ulusan, Vakur Olgaç, Semra DemokanDOI :10.26650/JARHS2021-1138086Toplantı ÖzetienS. 46-46A PHYLOGENETIC APPROACH TO EVALUATE THE RELATION BETWEEN miRNA EXPRESSIONS AND HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMAAyşe Banu DemirDOI :10.26650/JARHS2021-1135099Toplantı ÖzetienS. 47-47LONG NON-CODING RNAs AND AUTOPHAGY IN OSTEOSARCOMAAyça Coşkun, Hamza Malik OkuyanDOI :10.26650/JARHS2021-1134054Toplantı ÖzetienS. 48-48CircRNAs OF SALIVA AS POTENTIAL BIOMARKERS FOR COLORECTAL CANCER DIAGNOSISAfet Sattarova, Milad Asadi, Tayfun Yoldaş, Osman Bozbıyık, Ahmed Al Omar, Can Müftüoğlu, Ufuk Mert, Ayşe CanerDOI :10.26650/JARHS2021-1136772Toplantı ÖzetienS. 50-50EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPYSaina Rahimi, Milad Asadi, Can Müftüoğlu, Emin Tavlayan, Özlem Özkaya Akagündüz, Ufuk Mert, Ayşe CanerDOI :10.26650/JARHS2021-1136760Toplantı ÖzetienS. 51-51LIPOPOLYSACCHARIDE INHIBITS AUTOPHAGY IN HUMAN DERMAL FIBROBLASTS IN VITROKeyvan Hemmatvand, Mehtap Yüksel Eğrilmez, Ufkay KarabayDOI :10.26650/JARHS2021-1140330Toplantı ÖzetienS. 52-52microRNA AS A PROMISING POTENTIAL BIOMARKER FOR COLORECTAL CANCERMilad Asadi, Ayşe Caner, Venus Zafari, Ahmed Al Omar, Can Müftüoğlu, Tuoraj Asvadi KermaniDOI :10.26650/JARHS2021-1136752Toplantı ÖzetienS. 53-53POTENTIAL OF microRNAs AS A BIOMARKER FOR LARYNGEAL CANCERMilad Asadi, Ayşe Caner, Venus Zafari, Ahmed Al Omar, Can Müftüoğlu, Shahram GhasembaıglouDOI :10.26650/JARHS2021-1136729Toplantı ÖzetienS. 54-54S-100 PROTEIN EXPRESSION LEVELS AS A POTENTIAL PROGNOSTIC MARKER IN NEUROBLASTOMAGamze Sanlav, Burçin Baran, Deniz Kızmazoğlu, Selen Kum Özşengezer, Safiye Aktaş, Zekiye Altun, Nur OlgunDOI :10.26650/JARHS2021-1136890Toplantı ÖzetienS. 55-55ANALYSIS OF TRIBBLES HOMOLOG 3 (TRIB3) EXPRESSION LEVELS IN NEUROBLASTOMA: PRELIMINARY STUDYBurçin Baran, Gamze Sanlav, Deniz Kızmazoğlu, Selen Kum Özşengezer, Safiye Aktaş, Zekiye Altun, Nur OlgunDOI :10.26650/JARHS2021-1137378Toplantı ÖzetienS. 56-56INVESTIGATION OF METHYLATION AND EXPRESSION STATUS OF PAX1 GENE VIA EPIGENOMIC PROFILING IN ORAL MALIGNANT LESIONSArda Öztan, Gülsüm Ak, Murat Ulusan, Semra DemokanDOI :10.26650/JARHS2021-1142683Toplantı ÖzetienS. 57-57miRNA-REGULATED PATHWAYS OF CD8+ T CELLS IN TNBC MOUSE MODELMüge Öçal Demirtaş, Bala Gür DedeoğluDOI :10.26650/JARHS2021-1135358Toplantı ÖzetienS. 58-58INVESTIGATION OF THE EFFECT PISTACIA VERA FROM DIFFERENT REGIONS ON OXIDATIVE STRESS AND PROLIFERATION IN BREAST CANCER CELL LINEİpek Gürkebabçı, Başak Koçdor, Hilal KoçdorDOI :10.26650/JARHS2021-1145612Toplantı ÖzetienS. 59-59INVESTIGATION OF THE POTENTIAL EFFECTS OF YAP-1 AND NESTIN ON RISK CLASSES AND PROGNOSIS IN NEUROBLASTOMASelen Kum Özşengezer, Burçin Baran, Deniz Kızmazoğlu, Gamze Sanlav, Safiye Aktaş, Tekincan Aktaş, Zekiye Altun, Nur OlgunDOI :10.26650/JARHS2021-1136813Toplantı ÖzetienS. 60-60ANTIMETASTATIC POTENTIAL OF CUCUMIN IN ANAPLASTIC THYROID CANCER AND COMBINED ACTIVITY WITH DOCETAXELMehmet Ali Koçdor, Yağmur Kaya, Arzu Yıldırım, Hilal KoçdorDOI :10.26650/JARHS2021-1145546Toplantı ÖzetienS. 61-61INVESTIGATION OF THE ANTIMETASTATIC POTENTIAL OF T. SPICATA IN HUMAN BREAST ADENOCARCINOMA CELLS COMBINED WITH STANDARD CHEMOTHERAPYTarık Salman, Arzu Yıldırım, Yağmur Kaya, Hilal KoçdorDOI :10.26650/JARHS2021-1145563Toplantı ÖzetienS. 62-62EFFECT OF THYMOQUINONE IN COMBINATION WITH NIVOLUMAB ON EXPERIMENTAL RENAL CELL CANCER MODELSAhmet Dirican, Safiye Aktaş, Tekincan Aktaş, Aylin Erol, Özde Gökbayrak, Hatice Efsun Kolatan, Efe Özgür Serinan, Zekiye Sultan Altun, Işıl Somalı, Osman YılmazDOI :10.26650/JARHS2021-1133817Toplantı ÖzetienS. 63-63NETWORK AND PATHWAY BASED ANALYSIS OF MULTI-OMIC DATA TO ENLIGHTEN MOLECULAR MECHANISMS OF COMPLEX DISEASESBurcu Bakır GüngörDOI :10.26650/JARHS2021-1137390Toplantı ÖzetienS. 65-68